The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs
Bertilsson, L., Dahl, M., Dalén, P., & Al‐Shurbaji, A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01548.x · Cited by 579
Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H., & Sugiyama, Y. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01372-3 · Cited by 512
Crewe, H., Lennard, M., Tucker, G., Woods, F., & Haddock, R. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04134.x · Cited by 469
[10] Mechanism-based enzyme inactivators
Silverman, R. B. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)49038-8 · Cited by 384
Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models
Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012724 · Cited by 308
Self-citationMayhew, B. S., Jones, D. R., & Hall, S. D. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15182-3 · Cited by 293
Inhibition of Cytochrome P450 Enzymes
Correia, M. A., & Hollenberg, P. F. (2015) · Cytochrome P450 · doi:10.1007/978-3-319-12108-6_5 · Cited by 257
Venlafaxine oxidation in vitro is catalysed by CYP2D6
OTTON, S. V., BALL, S. E., CHEUNG, S. W., INABA, T., RUDOLPH, R. L., & SELLERS, E. M. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00173.x · Cited by 227
The relationship between paroxetine and the sparteine oxidation polymorphism
Sindrup, S. H., Brøsen, K., Gram, L. F., Hallas, J., Skjelbo, E., Allen, A., Allen, G. D., Cooper, S. M., Mellows, G., Tasker, T. C. G., et al. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.23 · Cited by 205
In Vitro Approaches to Predicting Drug Interactions In Vivo
von Moltke, L. L., Greenblatt, D. J., Schmider, J., Wright, C. E., Harmatz, J. S., & Shader, R. I. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00239-6 · Cited by 197
Self-citationBr�sen, K., Hansen, J. G., Nielsen, K. K., Sindrup, S. H., & Gram, L. F. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316471 · Cited by 193
von Moltke, L. L., Greenblatt, D. J., Court, M. H., Duan, S. X., Harmatz, J. S., & Shader, R. I. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199504000-00008 · Cited by 176
Self-citationFogelman, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00113-4 · Cited by 175
Interactions of amphetamine analogs with human liver CYP2D6
Wu, D., Otton, S. V., Inaba, T., Kalow, W., & Sellers, E. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00014-2 · Cited by 173
Moltke, L. L., Greenblatt, D. J., Cotreau-Bibbo, M. M., Duan, S. X., Harmatz, J. S., & Shader, R. I. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38622-2 · Cited by 156
Self-citationSindrup, S. H., Brøsen, K., & Gram, L. F. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.24 · Cited by 151
Jones, D. R., Gorski, J. C., Hamman, M. A., Mayhew, B. S., Rider, S., & Hall, S. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35013-x · Cited by 145
Franklin, M. R. (1971) · Xenobiotica · doi:10.3109/00498257109112269 · Cited by 134
The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.
Bloomer, J. C., Woods, F. R., Haddock, R. E., Lennard, M., & Tucker, G. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04082.x · Cited by 133
Bolton, J. L., Acay, N. M., & Vukomanovic, V. (1994) · Chemical Research in Toxicology · doi:10.1021/tx00039a024 · Cited by 130
Cytochrome P450 Enzyme System: Genetic Polymorphisms and Impact on Clinical Pharmacology
van der Weide, J., & Steijns, L. S. W. (1999) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329903600604 · Cited by 129
Alderman, J. A., Preskorn, S., Greenblatt, D. J., Harrison, W. M., Penenberg, D. N., Allison, J., & Chung, M. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00008 · Cited by 121
Self-citationMoltke, L. L., Greenblatt, D. J., Grassi, J. M., Granda, B. W., Venkatakrishnan, K., Schmider, J., Harmatz, J. S., & Shader, R. I. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06914.x · Cited by 108
Self-citationKerry, N., Somogyi, A., Bochner, F., et al. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04348.x · Cited by 107
Human Cytochromes and Some Newer Antidepressants: Kinetics, Metabolism, and Drug Interactions
Greenblatt, D. J., Moltke, L. L., Harmatz, J. S., et al. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910001-00003 · Cited by 100
Self-citationCheer, S. M., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161010-00010 · Cited by 97
Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers
Hemeryck, A., Lefebvre, R. A., DEVRIENDT, C., & Belpaire, F. M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104788 · Cited by 95
Haddock, R. E., Johnson, M. A., Langley, P. F., et al. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07163.x · Cited by 94
Alfaro, C. L., Lam, Y. W. F., Simpson, J., & Ereshefsky, L. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00011 · Cited by 94
Yamano, K., Yamamoto, K., Kotaki, H., et al. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14917-3 · Cited by 66
Belpaire, F. M., Wijnant, P., Temmermann, A., et al. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050456 · Cited by 58
Greenblatt, D. J., Moltke, L. L., Schmider, J., Harmatz, J. S., & Shader, R. I. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04252.x · Cited by 56
Self-citationVenkatakrishnan, K., Moltke, L. L., Duan, S. X., et al. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06859.x · Cited by 46
Self-citationÖzdemir, V., Naranjo, C. A., Shulman, R. W., Herrmann, N., Sellers, E. M., Reed, K. L., & KALOW, W. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00004 · Cited by 26
Hemeryck, A., Vriendt, C. D., & Belpaire, F. M. (2001) · PubMed · Cited by 23
Cited by
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01877 · Cited by 719
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522
Bousman, C. A., Stevenson, J. M., Ramsey, L. B., Sangkuhl, K., Hicks, J. K., Strawn, J. R., Singh, A. B., Ruaño, G., Mueller, D. J., Tsermpini, E. E., et al. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2903 · Cited by 521
Metadata
- Authors
- Bertelsen, K. M., Venkatakrishnan, K., von Moltke, L. L., Obach, R. S., & Greenblatt, D. J.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 31
- Issue
- 3
- Pages
- 289-293
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2103946220
- Cited by
- 276
- References
- 38
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.